Ibi Inv House (IBI) AI Stock Analysis

Ibi Inv House

(TASE:IBI)

Select Model

Rating:79Outperform

Price Target:ILA 44,357.00▲(13.53% Upside)

Action:upgraded

Date:09/06/26

IBI Investment House scores well on the strength of its financial performance, which carries the greatest weight: rapid revenue growth, expanding margins, a return on equity near 29%, and exceptional cash conversion with free cash flow nearly matching net income. Technicals reinforce the case, with the price trading above all key moving averages and momentum indicators still constructive, though the shares look near-term extended. The main offsets are a P/E of 24.7 that leaves limited valuation cushion, rising leverage with debt-to-equity roughly doubling since 2024, and the inherent cyclicality of brokerage and asset-management revenue. A 3.1% dividend yield and above-average share-price volatility (beta 1.47) round out the profile.

Positive Factors

Strong revenue and earnings growthSubstantial revenue and earnings growth indicates expanding business activity and improving profitability. If sustained, this combination can strengthen internal funding capacity, support reinvestment, and improve the company’s ability to compound earnings over the next several quarters.

Negative Factors

Rising leverageThe material increase in debt relative to equity reduces financial flexibility compared with 2024 and makes results more sensitive to weaker market conditions. Higher leverage can constrain future capital allocation and increase the importance of maintaining strong cash generation.

Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)

Market Cap: ILS 5.54B
Dividend Yield: 3.74%
Average Volume (3M): 13.93K
Price to Earnings (P/E): 20.4
Beta (1Y): 1.55
Revenue Growth: 44.48%
EPS Growth: 91.88%
Country: Israel
Employees: 1,078
Sector: General
Sector Strength: 55
Industry: Investment - Banking & Investment Services

Ibi Inv House Business Overview & Revenue Model

Company Description

I.B.I. Investment House Ltd provides various financial products and services in Israel and internationally. The company offers equity plan services, financial trusts, mergers and acquisitions, SmartForm, S CUBE valuations, IBI TRUST IL, IBI internati...

Ibi Inv House Financial Statement Overview

Summary

Strong across all three statements. The income statement (86) shows revenue expanding to roughly 1.77 billion TTM, up about 36% year over year, with net income near 266 million and margins widening (net ~15%, operating ~34%). Cash flow is the standout (88): operating cash flow of about 563 million and free cash flow of about 541 million, up roughly 54%, with free cash flow capturing ~96% of both operating cash flow and net income, confirming high-quality earnings. The balance sheet (76) is solid, with equity at roughly 42% of assets and a best-in-period return on equity near 29%, but leverage has risen with debt-to-equity climbing to about 0.52 from 0.27 in 2024. Earnings and cash flows remain cyclical and tied to capital-market activity, and the jump in reported gross margin appears to reflect a presentation change rather than an operational leap.

Income Statement

86Very Positive

Balance Sheet

76Positive

Cash Flow

88Very Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.77B	1.47B	1.04B	791.55M	660.61M	548.65M
Gross Profit	1.64B	1.40B	696.21M	511.24M	417.09M	357.00M
EBITDA	675.92M	494.39M	368.28M	293.07M	212.29M	227.69M
Net Income	266.16M	174.59M	178.14M	156.46M	90.76M	139.58M
Balance Sheet
Total Assets	2.30B	2.17B	1.85B	1.27B	1.08B	1.13B
Cash, Cash Equivalents and Short-Term Investments	750.73M	604.92M	519.23M	453.00M	246.53M	547.09M
Total Debt	378.21M	442.27M	243.90M	201.26M	154.42M	334.90M
Total Liabilities	1.10B	1.03B	750.27M	539.07M	399.48M	521.39M
Stockholders Equity	955.54M	918.42M	899.76M	686.62M	640.44M	575.47M
Cash Flow
Free Cash Flow	541.38M	290.24M	218.35M	207.56M	45.23M	190.60M
Operating Cash Flow	563.29M	307.53M	249.28M	269.65M	61.11M	197.55M
Investing Cash Flow	-95.41M	-100.26M	-97.88M	-269.38M	-44.08M	36.90M
Financing Cash Flow	-349.09M	-178.80M	-141.00K	-37.48M	-80.76M	-196.36M

Ibi Inv House Technical Analysis

Technical Analysis SentimentNegative

Last Price39070.00

Price Trends

50DMA42476.89Negative

100DMA44833.29Negative

200DMA41308.21Negative

Market Momentum

MACD-850.73Positive

RSI40.77Neutral

STOCH16.24Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Negative. The current price of 39070.00 is below the 20-day moving average (MA) of 40360.50, below the 50-day MA of 42476.89, and below the 200-day MA of 41308.21, indicating a bearish trend. The MACD of -850.73 indicates Positive momentum. The RSI at 40.77 is Neutral, neither overbought nor oversold. The STOCH value of 16.24 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

IL:IBI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
IL:IBI	79Outperform	ILS 5.49B	20.37	―	3.74%	44.48%	91.88%
IL:GNRS	76Outperform	ILS 4.81B	2.67	―	2.38%	73.89%	616.40%
IL:MRIN	74Outperform	ILS 2.77B	19.39	―	5.34%	27.33%	20.29%
IL:MTAV	57Neutral	ILS 9.46B	9.62	―	2.95%	28.78%	172.56%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

IL:IBI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
IL:IBI	IBI Investment House Ltd.	39070.00	17747.05	83.23%
IL:LAPD	Lapidoth Capital Ltd.	7729.00	-218.31	-2.75%
IL:MTAV	Meitav Dash Investments Ltd.	11200.00	979.04	9.58%
IL:MRIN	Y.D. More Investments Ltd.	3850.00	-208.85	-5.15%
IL:GNRS	Generation Capital Ltd.	228.40	108.16	89.95%
IL:MTRD	Meitav Trade Investments Ltd.	1780.00	-163.61	-8.42%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 06, 2026

Ibi Inv House AI Stock Analysis